Citigroup’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.16M Buy
880,603
+484,113
+122% +$2.29M ﹤0.01% 1530
2025
Q1
$1.82M Buy
396,490
+338,867
+588% +$1.56M ﹤0.01% 2151
2024
Q4
$276K Sell
57,623
-11,881
-17% -$56.9K ﹤0.01% 3376
2024
Q3
$326K Buy
69,504
+54,434
+361% +$255K ﹤0.01% 3264
2024
Q2
$85.1K Buy
15,070
+3,327
+28% +$18.8K ﹤0.01% 3566
2024
Q1
$48.3K Buy
11,743
+2,483
+27% +$10.2K ﹤0.01% 3902
2023
Q4
$39.1K Buy
9,260
+7,947
+605% +$33.5K ﹤0.01% 3906
2023
Q3
$5.67K Sell
1,313
-113,307
-99% -$489K ﹤0.01% 3961
2023
Q2
$755K Sell
114,620
-107,230
-48% -$707K ﹤0.01% 2441
2023
Q1
$1.51M Buy
221,850
+113,816
+105% +$773K ﹤0.01% 1712
2022
Q4
$798K Sell
108,034
-51,885
-32% -$383K ﹤0.01% 2219
2022
Q3
$1.58M Buy
159,919
+42,440
+36% +$419K ﹤0.01% 1767
2022
Q2
$1.28M Buy
117,479
+35,095
+43% +$382K ﹤0.01% 1878
2022
Q1
$932K Sell
82,384
-69,490
-46% -$786K ﹤0.01% 2410
2021
Q4
$2.38M Buy
151,874
+58,518
+63% +$918K ﹤0.01% 1837
2021
Q3
$1.6M Sell
93,356
-45,560
-33% -$781K ﹤0.01% 2061
2021
Q2
$2.99M Sell
138,916
-54,020
-28% -$1.16M ﹤0.01% 1812
2021
Q1
$2.9M Buy
192,936
+176,334
+1,062% +$2.65M ﹤0.01% 1708
2020
Q4
$219K Buy
16,602
+10,435
+169% +$138K ﹤0.01% 3182
2020
Q3
$60K Sell
6,167
-52,776
-90% -$513K ﹤0.01% 3392
2020
Q2
$674K Buy
58,943
+16,203
+38% +$185K ﹤0.01% 2367
2020
Q1
$443K Buy
42,740
+13,450
+46% +$139K ﹤0.01% 2349
2019
Q4
$480K Sell
29,290
-99,214
-77% -$1.63M ﹤0.01% 2654
2019
Q3
$1.71M Buy
128,504
+10,860
+9% +$144K ﹤0.01% 1728
2019
Q2
$1.66M Buy
117,644
+59,826
+103% +$843K ﹤0.01% 1779
2019
Q1
$1.06M Sell
57,818
-19,985
-26% -$368K ﹤0.01% 1930
2018
Q4
$2.03M Buy
77,803
+24,511
+46% +$640K ﹤0.01% 1525
2018
Q3
$1.22M Buy
53,292
+51,007
+2,232% +$1.17M ﹤0.01% 1844
2018
Q2
$43K Buy
2,285
+560
+32% +$10.5K ﹤0.01% 3961
2018
Q1
$29K Sell
1,725
-87,146
-98% -$1.47M ﹤0.01% 4047
2017
Q4
$1.35M Sell
88,871
-39,182
-31% -$595K ﹤0.01% 1698
2017
Q3
$2.29M Buy
128,053
+81,490
+175% +$1.46M ﹤0.01% 1404
2017
Q2
$759K Buy
46,563
+14,063
+43% +$229K ﹤0.01% 2159
2017
Q1
$456K Sell
32,500
-106,287
-77% -$1.49M ﹤0.01% 2462
2016
Q4
$2.21M Buy
138,787
+117,632
+556% +$1.88M ﹤0.01% 1746
2016
Q3
$351K Buy
21,155
+14,729
+229% +$244K ﹤0.01% 2663
2016
Q2
$72K Sell
6,426
-30,114
-82% -$337K ﹤0.01% 3521
2016
Q1
$305K Buy
36,540
+29,798
+442% +$249K ﹤0.01% 3132
2015
Q4
$63K Sell
6,742
-39,597
-85% -$370K ﹤0.01% 3918
2015
Q3
$523K Buy
46,339
+34,830
+303% +$393K ﹤0.01% 2171
2015
Q2
$146K Buy
11,509
+3,096
+37% +$39.3K ﹤0.01% 2988
2015
Q1
$78K Sell
8,413
-6,893
-45% -$63.9K ﹤0.01% 3572
2014
Q4
$219K Buy
15,306
+14,127
+1,198% +$202K ﹤0.01% 3087
2014
Q3
$12K Sell
1,179
-3,210
-73% -$32.7K ﹤0.01% 4536
2014
Q2
$71K Sell
4,389
-4,199
-49% -$67.9K ﹤0.01% 3310
2014
Q1
$140K Sell
8,588
-4,507
-34% -$73.5K ﹤0.01% 3197
2013
Q4
$162K Buy
13,095
+3,784
+41% +$46.8K ﹤0.01% 3323
2013
Q3
$102K Buy
9,311
+6,804
+271% +$74.5K ﹤0.01% 3115
2013
Q2
$21K Buy
+2,507
New +$21K ﹤0.01% 4180